This morning, UBS raised its price target on shares of Intel (NASDAQ:INTC) to $30 following strong third quarter results last night. The report said that the company's execution was able to compensate for a weak macroeconomic environment and UBS reiterated its buy rating.
Shares of Intel were higher on Wednesday, climbing 4.2% so far.
And Goldman Sachs increased its price target on shares of Intuitive Surgical (NASDAQ:ISRG) to $412 after the company raised its guidance. In the report, Goldman matched its EPS estimates to the new guidance, but maintained its neutral rating.
Shares of Intuitive Surgical were sharply higher, gaining 9.5% today.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.